Esposito Pamela
Kymera Therapeutics, Inc. · Director
Esposito Pamela is listed in filings as Director at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR). The current snapshot covers public activity from Sep 17, 2024 to May 19, 2026. Reported amounts are shown as $31.2K to $95.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $165k1.9k shares | SellFeb 20, 2026 | $87.06 | $113.99 | |
| $53k600 shares | SellFeb 20, 2026 | $88.10 | $113.99 | |
| $333k4.9k shares | SellJan 20, 2026 | $67.99 | $113.99 | |
| $27k400 shares | SellJan 20, 2026 | $66.68 | $113.99 | |
| $14k200 shares | SellJan 20, 2026 | $68.52 | $113.99 | |
| $1M14.5k shares | SellDec 17, 2025 | $81.56 | $113.99 | |
| $655k8k shares | SellDec 17, 2025 | $82.34 | $113.99 | |
| $342k4.1k shares | SellDec 17, 2025 | $83.45 | $113.99 | |
| $84k1k shares | SellDec 17, 2025 | $84.07 | $113.99 | |
| $245k5k shares | SellJun 3, 2025 | $49.04 | $113.99 | |
| $123k2.5k shares | SellDec 2, 2024 | $49.00 | $113.99 | |
| $349k7.2k shares | SellSep 17, 2024 | $48.75 | $113.99 | |
| $303k6.4k shares | SellSep 17, 2024 | $47.75 | $113.99 |